Novo Nordisk today announced that new data will be presented at the upcoming International Society on Thrombosis and ...

Sobi® today announced new data across its haemophilia portfolio will be presented at the 2026 Congress of the International Society on Thrombosis and Haemostasis (ISTH), taking place in Paris, from 11 ...

Sanofi R&D in its core haemophilia category is advancing on three fronts – engineered proteins, RNA interference drugs and gene therapies – and highlighted results in two of those at the International ...

(WASHINGTON, Apr. 8, 2026) — The American Society of Hematology (ASH) and the International Society on Thrombosis and Haemostasis (ISTH) released comprehensive clinical practice guidelines on ...

Seven oral presentations across the hemophilia portfolio reinforce Sanofi’s commitment to bring potential first- and best-in-class treatments to the rare blood disorders community Interim results from ...

The International Society on Thrombosis and Haemostasis (ISTH), the leading international professional medical-scientific organization dedicated to advancing the understanding, prevention, diagnosis, ...

CHARLOTTE, N.C., Dec. 8, 2025 /PRNewswire/ -- The International Society on Thrombosis and Haemostasis (ISTH) announces that its 2027 Congress will be held in the city of Vancouver, Canada, from June ...

(WASHINGTON—May 27, 2025) The American Society of Hematology (ASH) and the International Society on Thrombosis and Haemostasis (ISTH) released new and updated clinical practice guidelines for the ...

New analyses and real-world evidence highlight outcomes with Altuvoct, Elocta and Alprolix in haemophilia A and BSTOCKHOLM, June 30, 2026 /PRNewswire/ -- Sobi today announced new data across ...